News & Views
Michael McKelvey Retires from ERT
Mar 15 2011
ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries announced the retirement of President and CEO Dr. Michael J. McKelvey, at the year end, with Dr Joel Morganroth currently taking up the position prior to hiring a permanent replacement.
Dr Morganroth has served as the Chairman of ERT’s Board of Directors since 1999 and as Chief Scientific Officer since April 2006. He previously served as the company’s Chief Executive Officer from 1993 to March 2001 and also has consulted for ERT since 1977. Dr Morganroth is also a globally recognised cardiologist and clinical researcher and has had more than 10 years’ experience as a medical review officer/expert for the U.S. Food and Drug Administration (FDA).
Dr Morganroth commented: “We thank Dr.McKelvey for his years of service and wish him well in his future endeavours.”
Digital Edition
LMUK 49.7 Nov 2024
November 2024
News - Research & Events News - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan